RoukenBio
Biotechnology Research • 
Motherwell, Scotland, United Kingdom • 51-100 Employees
Company overview
| Headquarters | Antibody Analytics Discovery Centre, Braidhurst Industrial Estate, Newhut Rd, Motherwell, Scotland ML1 3ST, GB |
| Phone number | +441698534450 |
| Websites | |
| NAICS | 541714 |
| Keywords | CRO, Services, Drug Discovery, Biosimilars, Drug Development, Biologics, Method Development, Cell Therapy, Immunology, Bioassays, Adcs, Immuno-Oncology, Mabs, Cell Line Development, Nk Cells, Tumor Microenvironment, Adcc, Bi-Specifics, Dendritic Cells, Car-T, Checkpoint Inhibitors, Tregs, Macrophages, Immunotherapeutics, T Cell Activation, Tdcc, T Cells, Antibodytherapeutics, Immune Cell Engagers |
| Founded | 2015 |
| Employees | 51-100 |
| Socials |
Key Contacts at RoukenBio
Andy Upsall
Founder & Ceo
Andrea Bisso
Business Development Director
Emilio Cosimo
Scientific Director
Gavin Meehan
Associate Scientific Director
Andrew Baron
Scientific Director - Bioanalytical
Shona Campbell
Director, Computerised Systems & Strategic Projects
Daria Paruzina
Scientific Director Innovation
Timothy London
Director Of Molecular Biology & Cell Engineering
Shatakshi Sood
Associate Director Immunology
Robert Benson
Scientific Director At Roukenbio
RoukenBio Email Formats
RoukenBio uses 2 email formats. The most common is {first name}{last name} (e.g., johndoe@rouken.bio), used 94% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}{last name} | johndoe@rouken.bio | 94% |
{first initial}{last name} | jdoe@rouken.bio | 6% |
About RoukenBio
RoukenBio – CRO redefined. RoukenBio takes its tagline seriously - disrupting the traditional CRO model with a collaborative, personalised approach to drug discovery. With customers in over 27 countries, RoukenBio aims to become the most trusted research partner to biotherapeutic innovators globally. Backed by brilliant minds, RoukenBio offers a range of in vitro drug discovery services with specialist expertise across human immunology, bioanalytical, cell line engineering, molecular biology, bioassay development and safety and efficacy assessments. RoukenBio partners with therapeutic developers from early discovery, through IND-enabling pivotal data studies, to ‘GMP-ready’ potency assay creation. Working across inflammation, auto-immunity, immuno-oncology and oncology, their team focuses on novel and emerging therapeutic classes including antibodies, cell therapies, nanoparticles, small molecules, protein degraders, peptides, recombinant proteins, vaccines, antibody drug conjugates and more. RoukenBio embraces change and drives innovation with unique services, like the customisable inducible cell line platform, IndEx-2, to stay ahead of the curve. RoukenBio’s assay solutions recreate disease state pathologies as faithfully as possible, and combined with a thought-partner approach to research collaborations, the RoukenBio team uses their scientific empathy to propel their customer’s therapeutic development projects forward.
RoukenBio revenue & valuation
| Annual revenue | $8,298,835 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $26,600,000 |
| Total funding | No funding |
Employees by Management Level
Total employees: 51-100
Seniority
Employees
Employees by Department
RoukenBio has 22 employees across 7 departments.
Departments
Number of employees
Funding Data
RoukenBio has never raised funding before.
RoukenBio Tech Stack
Discover the technologies and tools that power RoukenBio's digital infrastructure, from frameworks to analytics platforms.
Cookie compliance
JavaScript libraries
JavaScript libraries
Maps
Advertising
Analytics
Miscellaneous
Security
Analytics
Font scripts
PaaS
JavaScript frameworks
United States
Sweden
Liechtenstein
BrazilFrequently asked questions
4.8
40,000 users
